"GLP-1 receptor agonists and the risk of thyroid cancer." Nested case-control study, Diabetes Care
The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use
Pickart, L., & Freedman, J
Only patients who lost 5% body weight during the 12-week intensive lifestyle lead-in period entered the 72-week randomized treatment period
Reported side effects in human anecdotal use are generally mild and may include: Mild nausea, particularly with oral administration Redness, itching, or irritation at the injection site Temporary dizziness or mild headache Changes in appetite or weight A significant theoretical concern revolves around its pro-angiogenic properties